SOLY

NASDAQ

Soliton, Inc.

SectorHealth CareIndustryMedical/Dental InstrumentsIPO2019

News25/Ratings0

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.

Latest news

25 items

1577dSEC
SEC Form 15-12B filed by Soliton, Inc.
15-12B - Soliton, Inc. (0001548187) (Filer)
1583dSEC
SEC Form EFFECT filed by Soliton, Inc.
EFFECT - Soliton, Inc. (0001548187) (Filer)
1583dSEC
SEC Form EFFECT filed by Soliton, Inc.
EFFECT - Soliton, Inc. (0001548187) (Filer)
1583dSEC
SEC Form EFFECT filed by Soliton, Inc.
EFFECT - Soliton, Inc. (0001548187) (Filer)
1585d13D/G
SEC Form SC 13D/A filed by Soliton, Inc. (Amendment)
SC 13D/A - Soliton, Inc. (0001548187) (Subject)
1588dINSIDER
SEC Form 4: Remeditex Ventures Llc returned $208,242,660 worth of shares to the company (9,214,277 units at $22.60)
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4: Tanner Joe D returned $1,808,000 worth of shares to the company (80,000 units at $22.60), closing all direct ownership in the company
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4: Klemp Walter V returned $9,605,000 worth of shares to the company (425,000 units at $22.60), closing all direct ownership in the company
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4 filed by Kaminer Michael S.
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4 filed by Hunt Niquette L.
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4 filed by Hauser Bradley
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4 filed by Harrison Danika R
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4 filed by Foster Jonathan P.
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4: Capelli Christopher returned $9,908,744 worth of shares to the company (438,440 units at $22.60), closing all direct ownership in the company
4 - Soliton, Inc. (0001548187) (Issuer)
1588dINSIDER
SEC Form 4: Bisson Lori returned $1,356,000 worth of shares to the company (60,000 units at $22.60), closing all direct ownership in the company
4 - Soliton, Inc. (0001548187) (Issuer)
1589dSEC
SEC Form S-8 POS filed by Soliton, Inc.
S-8 POS - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form S-8 POS filed by Soliton, Inc.
S-8 POS - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form S-8 POS filed by Soliton, Inc.
S-8 POS - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form POS AM filed by Soliton, Inc.
POS AM - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form POS AM filed by Soliton, Inc.
POS AM - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form POS AM filed by Soliton, Inc.
POS AM - Soliton, Inc. (0001548187) (Filer)
1589dSEC
SEC Form 25-NSE filed by Soliton, Inc.
25-NSE - Soliton, Inc. (0001548187) (Subject)
1589dSEC
Soliton, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Soliton, Inc. (0001548187) (Filer)
1589dPR
Allergan Aesthetics Completes Acquisition of Soliton
IRVINE, Calif., Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE:ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ:SOLY). The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to now include a proven treatment for the appearance of cellulite. The RESONIC™ device initially received U.S. Food and Drug Administration (FDA) 510(k) clearance for the short-term improvement in the appearance of cellulite, and that clearance has now been expanded to long-term improvement up to one year. In recent clinical data submitted to the FDA, RESONIC™ demonstrated sig
1590dNEWS
50 Biggest Movers From Yesterday
Gainers Sidus Space, Inc. (NASDAQ:SIDU) shares jumped 143.8% to settle at $12.19 on Tuesday after the company priced its IPO at $5 per share, MIND Technology, Inc. (NASDAQ:MIND) gained 29.9% to close at $1.78 on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division. Alzamend Neuro, Inc. (NASDAQ:ALZN) jumped 28.3% to close at $3.08 after gaining 9% on Monday. Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) gained 23.8% to settle at $8.26. Reneo Pharmaceuticals, last month, posted a Q3 loss of $0.52 per share. Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) surged 22% to c